drugset / Trial / NCT00509743

Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac Sodium

NCT00509743

Phase 1 Completed 89 enrolled Javelin Pharmaceuticals
NaSingle-groupOpen-label

Summary

The purpose of this study is to assess the effects of age, weight, and body composition on the pharmacokinetic profile, safety, and tolerability of intravenous diclofenac sodium (DIC075V) in adult volunteers.

Timeline

Start
2007-09
Primary completion
2008-02
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified Intravenous

Indications

No indication recorded.